Ionis Pharmaceuticals IONS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's PP&E (net)?
- Ionis Pharmaceuticals (IONS) reported PP&E (net) of $142.4M in Q1 2026.
- How has Ionis Pharmaceuticals's PP&E (net) changed year-over-year?
- Ionis Pharmaceuticals's PP&E (net) increased by 38.4% year-over-year, from $102.93M to $142.4M.
- What is the long-term trend for Ionis Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's PP&E (net) has grown at a -7.4% compound annual growth rate (CAGR), from $181.08M to $123.05M.
- What does PP&E (net) mean?
- The value of the company's physical assets like buildings and equipment after accounting for wear and tear.
- How do you interpret PP&E (net)?
- Increasing values suggest capital investment in infrastructure, while decreasing values may indicate asset depreciation or divestiture.
- How does PP&E (net) compare across companies?
- Highly dependent on whether the company owns its manufacturing facilities or outsources production.